ILDSTAD SUZANNE enters TOURMALINE BIO, INC. with 6.11M shares across direct and indirect positions
This filing by ILDSTAD SUZANNE (Chief Scientific Officer) establishes the baseline for all future Form 4 insider transaction reports at TOURMALINE BIO, INC..
Direct Indirect
Filed: 5/6/2021ACC: 0000899243-21-018527
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
6.11M
Baseline shares
79% direct
4.81M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
3
Security positions
1.31M indirect
Non-Derivative Holdings3
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned654.21K
Common Stock
DirectShares owned4.81M
Total
4.81M direct·1.31M indirect6.11M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 654.21K | Indirect |
| Common Stock | 4.81M | Direct |
| Total | 6.11M | 4.81M direct·1.31M indirect |
Derivative Holdings0
No derivative holdings reported